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Therapeutic strategies using drugs which cause Lysosomal <:cil Death have been proposed for eradication of 
resistant cancer cells. In this context, nanotherapy based on Magnetic Intra-Lysosomal Hyperthermia (MILH) 
generated by magnetic nanoparticles (MNPs) that are grafted with ligands of receptors overexpressed in tumors 
appears to be a very promising therapeutic option. However, mechanisms whereby MILH induces cell death are 
still elusive. Herein, using Gastrin-grafted MNPs specifically delivered to lysosomes of tumor cells from different 
cancers, we provide evidences that MILH causes cell death through a non--apoptotic signaling pathway. The 
mechanism of cell death involves a local temperature elevation at the nanoparticle periphery which enhances the 
production of reactive oxygen species through the lysosomal Fenton reaction. Subsequently, MILH induces lipid 
peroxidation, lysosomal membrane permeabilization and leakage of lysosomal enzymes into the cytosol, in­
cluding Cathepsin-B which activates Caspase-1 but not apoptotic Caspase-3. These data highlight the clear po­
tential of MILH for the eradication of tumors overexpressing reœptors. 
1. Introduction
Cancer is a leading cause of death with millions of new people di 
agnosed with cancer every year. One major reason that limits outcome 
and drug response of anti cancer therapies is multidrug resistance (1). 
However, reœnt studies have shown that cancer cells resistant to tra 
ditional therapies can be sensitive to agents which induce lysosomal 
cell death through lysosome membrane pa-meabilization (LMP) (2). In 
fact, LMP can be triggered by a wide variety of stimuli including death 
ligands, oxidative stress and treatment by lysosomotropic agents (3). In 
some circumstances (i.e. treatment by lysosomotropic agents), LMP 
appears to be an early event triggering apoptosis whereas in others (i.e. 
treatment by death ligands), LMP results from the activation of apop 
tosis signaling pathways and contributes to the amplification of death 
signais. 
Alternatively to these above agents, we (4) and others (5,6) have 
reœntly proposed that Magnetic Intra Lysosomal Hyperthermia 
(termed MILH), induced by application of a high frequency altemating 
magnetic field (AMF) to cells containing magnetic nanoparticles 
(MNPs) in their lysosomes, is an effective way to specifically trigger 
lysosomal cell death in cancer cells (7). This is the result of the heat 
released by MNPs when exposed to AMF. Moreover, MNPs offer the 
potential to be driven into lysosomes of tumor cells by grafting them 
with ligands or antibodies that recognize receptors overexpressed in 
tumors. Subsequently to their activation, receptors are intemalized 
together with ligand grafted MNPs and traffic to lysosomes [ 4,5). Using 
this strategy, we showed that minute amounts of iron oxide MNPs 
targeting gastrin reœptors (CCK2R), overexpressed in most endocrine 
tumors, caused the death of cancer cells upon AMF exposure, making 
this appro ach an attractive therapeutic option [ 4,8). Strikingly, in this 
study, as in others, no perceptible temperature rise in the cell medium 
occurred during AMF exposure [ 4 6). Thus, MILH differs from standard 
magnetic hyperthermia whereby tumor eradication is achieved with 
large doses of MNPs which cause a temperature elevation of the whole 
tumor (9). However, it cannot be excluded that MILH also contributes 
to cell death during standard magnetic hypa-thermi a experiments since 
small amounts of MNP injected intra tumourously could be intemalized 
by cancer cells. In MILH, it is expected that MNPs, even oflow heating 
power (Specific Absorption Rate), generate a local temperature rise 
causing LMP (4 6,10). However, this appealing hypothesis has never 
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overnight and incubated with Gastrin MNPs (16 μg Fe/ml) for 24 h at
37 °C in medium buﬀered with 10 mM HEPES buﬀer pH 7.4 containing
0.5% FBS and 100 IU/ml penicillin streptomycin to allow Gastrin MNPs
internalization and accumulation in lysosomes. Incubation medium was
withdrawn and cells were rinsed twice with incubation medium and
then incubated with 5 mM NAC, 1 mM DFO, 1 nM BafA1, 20 μM ART,
10 μM CA 074 Me, 2.5 μM Caspase 1 inhibitor or 10 μM Caspase 3 in
hibitor for 1 h or 120 μM FeCl3 for 4 h and exposed to AMF (275 kHz,
40 mT) for 2 h using a commercial magnetic inductor (Fives Celes,
Lautenbach, France) as previously described [4]. The temperature of
the Cellview dish was maintained at 37.0 ± 0.2 °C and controlled
using a thermal probe (Reﬂex, Neoptix, Canada) placed in the incuba
tion medium of the cells. At the end of the experiments, cells were
placed in a humidiﬁed atmosphere at 5% CO2 and 37 °C. Diﬀerent
biological eﬀects were analyzed following AMF exposure and sum
marized in Supplementary Table 1.
2.4. Determination of cell death
The eﬀects of AMF treatment were investigated as follows: ﬁrst, cell
survival was determined 24 h post AMF treatment using a MTT viability
assay. Secondly, dead cells labeled with AnnexinV iFluor488 and pro
pidium iodide (excitation: 488 and 540 nm respectively, AAT Bioquest)
were counted 4 h after the end of AMF exposure as described before [4].
To analyze cell death in INR1G9 CCK2R overexpressing GFP CathB or
Casp1 fusion protein, INR1G9 CCK2R cells were seeded at a density of
25×103 cells/cm2 cells onto 35 mm dishes and transfected with 3 μg of
pCathB eGFP, pCathB C29A eGFP (given by Klaudia Brix, Jacobs Uni
versity Bremen, Germany) or pMSCV2.2 IRES GFP Caspase 1 C284A
(given by Dr. Petr Broz, University of Basel, Switzerland) using Lipo
fectamine 2000 reagent (Life technologies). 4 h post transfection, cells
were seeded onto 4 compartment Cellview dishes (Greiner Bio One) at
a density of 25×103 cells/cm2, grown overnight and incubated with
Gastrin MNPs (16 μg Fe/ml) for 24 h at 37 °C in medium buﬀered with
10 mM HEPES buﬀer pH 7.4 containing 0.5% FBS and 100 IU/ml pe
nicillin streptomycin. Cells were rinsed twice with incubation medium,
exposed to AMF for 2 h, labeled with AnnexinV iFluor555 (excitation:
540 nm, AAT Bioquest) 4 h after the end of AMF exposure and counted.
Counting of labeled cells was carried out by analyzing confocal mi
croscopy images (LSM510 confocal microscope, Zeiss) representing
populations of 2000 3000 cells/experiment using ImageJ software.
2.5. Analysis of ROS production
INR1G9 CCK2R cells were seeded 24 h before the experiments onto
4 compartment Cellview dishes (Greiner Bio One) at a density of 25 to
50×103 cells/cm2 and incubated with Gastrin MNPs (16 μg Fe/ml) for
24 h. Cells were rinsed twice with incubation medium and incubated
with 5 mM NAC, 1 mM DFO, 1 nM BafA1, 20 μM ART for 1 h or 120 μM
FeCl3 for 4 h. For total ROS production analysis, cells were exposed to
AMF for 2 h, rinsed with incubation medium, incubated with CellROX
Green reagent (Molecular probes, Excitation wavelegnth: 488 nm),
immediately after AMF exposure, in incubation medium according to
manufacturer's instructions and quantiﬁcation of ROS production was
performed by analyzing the intensity of CellROX Green reagent labeling
of confocal microscopy images (LSM780 confocal microscope, Zeiss)
using Image J software. 2000 3000 cells/experiments were analyzed in
at least 4 independent experiments. For initial ROS production analysis,
cells having or not internalized Gastrin MNPs were incubated in the
presence or absence of 1 mM DFO, 1 nM BafA1, 20 μM ART or 120 μM
FeCl3 and then with CellROX Green reagent (Molecular probes,
Excitation: 488 nm) in incubation medium according to manufacturer's
instructions, exposed to AMF for 30 min, rinsed with incubation
medium and ROS production was analyzed using confocal microscopy
(LSM780 confocal microscope, Zeiss) immediately after AMF exposure.
Initial ROS production was quantiﬁed by ﬂuorescence intensity ratio of
been directly proven experimentally. Moreover, the precise mechan 
isms leading to cell death by MILH remains largely unknown. Insight 
into these mechanisms is essential to optimize this approach in a 
therapeutic perspective.
To date, molecular mechanisms of lysosomal cell death of epithelial 
cells were mainly elucidated using lysosomotropic agents or death li 
gands which do not exclusively target lysosomes of cancer cells 
[11 13]. Lysosomal cell death through apoptosis was demonstrated to 
involve the release of lysosomal hydrolases into the cytosol, especially 
Cathepsin D and Cathepsin B (CathB) which digest apoptosis regulated 
proteins, leading to mitochondrial outer membrane permeabilization 
(MOMP) and apoptotic caspases activation [3,14].
The aim of this study was to elucidate the cellular and molecular 
mechanisms involved in cancer cell death induced by MILH. Here, we 
report that, under an AMF, lysosome accumulated MNPs increase the 
temperature very locally and enhance reactive oxygen species (ROS) 
production through the Fenton reaction within lysosomes. This causes 
lipid peroxidation of lysosome membrane, LMP and subsequent cell 
death by a non conventional mechanism which is dependent on 
Caspase 1 and CathB but independent of apoptotic Caspase 3. These 
major advances in the understanding of the cell death mechanism oc 
curring during MILH will facilitate optimization of the strategy in a 
therapeutic perspective.
2. Material and methods
2.1. Nanoparticles functionalization
The synthesis method and characterization of the magnetic nano 
platform used in the present article have been previously described [4]. 
The nanoplatform (Gastrin MNP) is composed of commercial iron oxide 
magnetic nanoparticles (MNPs) coated with PEG Amine (Gecco Dots, 
Sweden) and decorated with 100 molecules of a synthetic replicate of 
gastrin (Covalab) and 20 molecules of the ﬂuorescent label NHS 
DY647 PEG1 (Dyomics GmbH, Jena, Germany). The size of the mag 
netic core determined by transmission electron microscopy was 
8.7 ± 1.6 nm. The speciﬁc absorption rate of these MNPs is 13 W/g Fe 
at 275 kHz and 40 mT. N acetyl cystein (NAC), Desferroxamine (DFO), 
Baﬁlomycine A (BafA1), Artesunate (ART) and FeCl3 were purchased 
from Sigma Aldrich. CA 074 Me and Caspase 3 inhibitors were from 
ApexBio. Caspase 1 inhibitor was from Santa Cruz Biotechnologies.
2.2. Cell lines
The glucagon producing Hamster tumoral cell line INR1G9 stably 
expressing CCK2R (INR1G9 CCK2R) obtained as previously described 
[15] and the Thp1 human macrophage/monocyte cell line were cul 
tured in RPMI1640 medium containing 10% fetal bovine serum (FBS) 
and 100 IU/ml penicillin/streptomycin (Life technologies). The 
HEK293 cells (Flp In system, Invitrogen) stably expressing the CCK2R, 
named HEK CCK2R, and the clone B13 of AR4 2J cells (kindly provided 
by Pr Timo Otonkoski, University of Helsinki, Finland, with the per 
mission of Dr. Itaru Kojima, Gunma University, Maebashi, Japan) were 
cultured in DMEM medium containing 10% fetal bovine serum (FBS) 
and 100 IU/ml penicillin/streptomycin (Life technologies). The AGS 
gastric adenocarcinoma cell line was permanently transfected with 
CCK2R (AGS CCK2R) driven by the EF1 α promoter under puromycin 
selection and grown in DMEM/F 12 medium supplemented with 10%
FBS and 100 IU/ml penicillin/streptomycin [16]. The cells were grown 
in a humidiﬁed atmosphere at 95% air and 5% CO2 at 37 °C.
2.3. Cell treatment by alternating magnetic ﬁeld
Cell treatment by alternating magnetic ﬁeld (AMF) was performed 
as follows. Cells were seeded into 4 compartment Cellview dishes 
(Greiner Bio One) at a density of 25 to 50 × 103 cells/cm2, grown
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CellROX Green reagent to Gastrin MNP labeling of confocal microscopy
images (LSM780 confocal microscope, Zeiss) using Image J software.
20 30 cells/experiment were analyzed from at least 4 independent
experiments.
2.6. Local heat quantiﬁcation using molecular thermometers
INR1G9 CCK2R cells were seeded at a density of 25 × 103 cells/cm2
onto 35 mm dishes and transfected with 0.1 μg of YFP Lamp1
(Addgene, plasmid #1816) and 2.9 μg of pcDNA3 using Lipofectamine
2000 reagent (Life technologies). 24 h post transfection, cells were in
cubated with Gastrin MNP DY549 (16 μg Fe/ml) for 24 h, included in
0.5% agarose gel. For these experiments, the AMF was produced by a
miniaturized home made electromagnet placed in a CELLView dish and
covered with RPMI containing 0.5% FBS, as previously described [17].
This permits to follow in real time the evolution of the ﬂuorescence of
the MNPs under the application of AMF and thus to have an access to
the local temperature. For these experiments, diﬀerent positions were
marked inside and outside the gap. Cells were exposed to the AMF
(53 mT, 300 kHz). Before and during AMF application, ﬂuorescence
intensities of DY549 (excitation: 540 nm) and YFP Lamp1 (excitation:
510 nm) were measured from confocal microscopy images LSM780
confocal microscope, Zeiss) using ImageJ software. 20 30 cells/ex
periment were analyzed from 4 independent experiments.
2.7. CathB leakage from lysosome
INR1G9 CCK2R cells were seeded at a density of 25 × 103 cells/cm2
onto 35 mm dishes and transfected with 0.1 μg of RFP Lamp1
(Addgene, plasmid#1816), pCathB eGFP (given by Klaudia Brix, Jacobs
University Bremen, Germany) and 2.9 μg of pcDNA3 using
Lipofectamine 2000 reagent (Life technologies). 4 h post transfection,
cells were seeded onto 4 compartment Cellview dishes (Greiner Bio
One) at a density of 25 × 103 cells/cm2, grown overnight and in
cubated with Gastrin MNPs (16 μg Fe/ml) for 24 h, rinsed twice with
incubation medium and exposed to AMF for 2 h. CathB leakage from
lysosome was analyzed by measuring the colocalization between the
GFP CathB and RFP Lamp1 proteins and the ﬂuorescence intensity ratio
of GFP CathB to RFP Lamp1 labelings (excitation: 488 and 540 nm re
spectively) of confocal microscopy images (LSM780 confocal micro
scope, Zeiss, ImageJ software) immediately after AMF exposure. 20 30
cells/experiment were analyzed from 4 independent experiments.
For real time analysis of CathB leakage, INR1G9 CCK2R cells were
seeded at a density of 25 × 103 cells/cm2 onto 35 mm dishes and
transfected with 0.1 μg of pCathB eGFP (given by Klaudia Brix, Jacobs
University Bremen, Germany), 0.1 μg RFP Lamp1 (Addgene, plasmid
#1817) and 2.8 μg of pcDNA3 using Lipofectamine 2000 reagent (Life
technologies). 24 h post transfection, cells were incubated with Gastrin
MNPs (16 μg Fe/ml) for 24 h. INR1G9 CCK2R cells expressing or not
GFP CathB and having or not internalized Gastrin MNP were included
in 0.5% agarose gel, poured into the electromagnet placed in a
CELLView dish and covered with RPMI containing 0.5% FBS, as pre
viously described [17]. Diﬀerent positions were marked inside and
outside the gap. Cells were exposed to the AMF (53 mT, 300 kHz) for
60 min. Before and during AMF application, CathB leakage from lyso
some was analyzed by measuring the colocalization between the GFP
CathB and RFP Lamp1 proteins labeling from confocal microscopy
images of the marked positions by measuring the % of green pixels
(GFP CathB) colocalized with red pixels (RFP Lamp1) (ImageJ soft
ware). 20 30 cells/experiment were analyzed from 4 independent ex
periments.
2.8. Analysis of Caspase 1 and 3 activation
Cells were seeded 24 h before the experiments onto 4 compartments
Cellview dishes (Greiner Bio One) at a density of 25 to 50 × 103 cells/
cm2 and incubated with Gastrin MNPs (16 μg Fe/ml) for 24 h and ex
posed to AMF for 2 h. Immediately, 3 or 17 h after AMF exposure, cells
were incubated with Fluorochrome Labeled Inhibitors of Caspase 1
(FLICA, FAM YVAD FMK, excitation: 488 nm) or Caspase 3 (FLICA,
FAM DEVD FMK, excitation: 488 nm) reagent (Immunochemistry
technologies) for 1 h according to manufacturer's instructions. As a
positive control for Caspase 3 activation, INR1G9 CCK2R cells were
incubated with 1 μM staurosporine for 4 h. In some experiments, cells
were pretreated with 2.5 μM Caspase 1 inhibitor, 10 μM Caspase 3 in
hibitor or 10 μM CA 074 Me CathB inhibitor for 1 h. Inhibitors were
washed from the cells before adding FLICA. Next, cells were washed
and analyzed by confocal micrsocopy (LSM510 confocal microscope,
Zeiss). After Caspase 1 staining, cells were labeled with AnnexinV
iFluor555 according to manufacturer's instruction (AAT Bioquest).
Counting of labeled cells was carried out by analyzing confocal mi
croscopy images representing populations of 2000 3000 cells/experi
ment using ImageJ software.
2.9. Statistical analysis
Results are expressed as the mean ± SEM of at least three in
dependent experiments. Statistical analysis was performed using
ANOVA test. Diﬀerences were considered signiﬁcant when p < 0.05.
Fig. 1. Magnetic Intra-Lysosomal Hyperthermia (MILH) induces ROS generation.
a) Schematic representation of MILH approach. Gastrin-MNPs are speciﬁcally internalized through a CCK2R-dependent physiological process, and are then traﬃcked to lysosomes where
they accumulated. Upon AMF exposure, Gastrin-MNPs cause LMP and the leakage of lysosomal enzymes into the cytosol including Cathepsins which trigger cell death. Subsequently,
19.9 ± 1.5% or 32.3 ± 2.7% of INR1G9-CCK2R cells were labeled by AnnV and PI or killed 4 h and 24 h after AMF exposure. b) Top panel: hypothesis of initiating event triggered by
MILH. AMF application to cells containing MNPs would generate a local temperature elevation and enhance ROS production within lysosomes. Lysosomes are well-known major sites of
ROS production through the Fenton reaction which catalyzes the transformation of hydrogen peroxide to hydroxyl radicals. Bottom panel: INR1G9-CCK2R cells having or not internalized
Gastrin-MNPs were incubated in the presence or absence of 1 mM DFO, 120 μM FeCl3, 1 nM BafA1 or 20 μM ART, exposed or not to AMF and incubated with CellROX reagent.
Quantiﬁcation of ROS production was performed by analyzing the ﬂuorescence intensity from confocal microscopy images and expressed as fold change of ﬂuorescence intensity over
control cells (in absence of Gastrin-MNP and AMF). Signiﬁcant diﬀerence compared to the control condition corresponding to cells devoid of Gastrin-MNP in absence of AMF exposure
was indicated above histogram bar. Statistical signiﬁcances between other conditions are also indicated by lines/brackets. 2000–3000 cells/experiments were analyzed and results are the
mean ± SEM of 4 separate experiments. c) INR1G9-CCK2R cells having or not internalized Gastrin-MNPs were incubated in the presence or absence of 1 mM DFO, 120 μM FeCl3, 1 nM
BafA1 or 20 μM ART and incubated with CellROX reagent during the 30-min of AMF exposure. Top panel: confocal microscopy images illustrating ROS production, Gastrin-MNP labelings
and line scan of ﬂuorescence intensity. Bottom panel: Quantiﬁcation of ROS production colocalizing with Gastrin-MNP was performed by analyzing the % of relative ﬂuorescence
intensities of ROS production over Gastrin-MNP from confocal microscopy images. Signiﬁcant diﬀerence compared to the control condition corresponding to cells containing Gastrin-
MNP in absence of AMF exposure was indicated above histogram bar. Statistical signiﬁcances between other conditions are also indicated. 30–50 lysosomes of 20–30 cells/experiments
were analyzed and results are the mean ± SEM of 4 separate experiments. d) INR1G9-CCK2R cells were incubated with Gastrin-MNPs and exposed or not to AMF. Fe contained in
superparamagnetic MNPs was measured by particle electron paramagnetic resonance. e) INR1G9-CCK2R cells transiently expressing YFP-Lamp1 were incubated with Gastrin-MNP-
DY549. AMF was applied using a miniaturized electromagnet. Temperature at MNPs surface and lysosome membrane was analyzed respectively using the molecular thermometers DY549
(red line) and YFP-Lamp1 (green line) by measuring the decrease of their ﬂuorescence intensity. Signiﬁcant diﬀerence was analyzed comparatively to t= 0 for each ﬂuorophores. 20–30
cells/experiments were analyzed and results are the mean ± SEM of 5 separate experiments. As a control, no signiﬁcant changes of the MNP surface (red dotted line) or lysosome
membrane (green dotted line) temperatures were observed in cells not exposed to AMF. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
and pharmacological agents were carried out. Firstly, analysis of con
focal microscopy images indicated that ﬂuorescent ROS sensor co lo
calized with Gastrin MNPs in lysosomes after 30 min of AMF exposure
(Fig. 1c). Quantiﬁcation of lysosomal ROS images showed that MILH
enhanced ROS level by 2.0 ± 0.2 fold in the vicinity of Gastrin MNPs
within lysosomes (% of relative ﬂuorescence Gastrin MNP/ROS:
48.5 ± 3.9% vs 24.8 ± 1.1%). Moreover, addition of FeCl3 aug
mented MILH induced lysosomal ROS production by 1.3 ± 0.1 fold (%
of relative ﬂuorescence Gastrin MNP/ROS: 60.7 ± 6.1% vs
48.5 ± 3.9%), wheareas DFO inhibited it (37.8 ± 5.8%). Variation of
lysosomal pH also modiﬁed lysosmal ROS production. Indeed, while
ART treatment increased MILH induced lysosomal ROS production by
1.7 ± 0.1 fold (% of relative ﬂuorescence Gastrin MNP/ROS:
80.9 ± 8.5% vs 48.5 ± 3.9%), BafA1 inhibited it (24.7 ± 4.2%).
Together, these results demonstrate that MILH initially generates ROS
through the Fenton reaction within lysosomes where Gastrin MNPs are
accumulated.
However, as the ROS production can occur in other subcellular sites,
we also determined whether MILH also generates ROS by activating, for
instance, the mitochondrial respiratory chain complex or NADPH oxi
dases which are transmembrane proteins mostly present at the plasma
membrane, in endosomes and in endoplasmic reticulum [23]. We found
that rotenone, an inhibitor of the mitochondrial respiratory chain
complex, did not modify cellular ROS generation by MILH, whereas
diphenyleneiodonium (DPI), an inhibitor of NADPH oxidases, de
creased it (5.9 ± 1.8 and 3.8 ± 1.3 fold over basal value in the
presence of rotenone or DPI, respectively versus 5.7 ± 1.5 fold) (Fig.
S2). Hence, MILH initially triggers ROS production through the Fenton
reaction within lysosomes and, likely secondary, through NADPH oxi
dases. Of note, no signiﬁcant variation in ROS level was observed be
tween the diﬀerent conditions in the absence of AMF exposure (Fig.
S1a, S2).
We further investigated the mechanism whereby MILH enhanced
the Fenton reaction in lysosomes. Firstly, we examined the possibility
that Fe ions, participating in the Fenton reaction, could originate from
MNPs dissolution in lysosomes during AMF exposure. Indeed, it has
been reported that iron oxide MNPs, in the absence of AMF application,
are degraded through a lysosomal acidic and enzymatic lysis in the
endo lysosome compartment [24,25]. On the other hand, another study
performed at neutral pH, attributed ROS production to the catalytic
reaction at the surface of MNPs rather than to being caused by dissolved
iron from MNPs [26]. Using particle electron paramagnetic resonance
(pEPR) to determine the quantity of iron contained in the cells under
the form of MNPs, we found that internalized Gastrin MNPs were not
degraded following AMF application (0.94 ± 0.06 vs 0.92 ± 0.03 pg
magnetic Fe/cell) (Fig. 1d). However, we cannot exclude that iron
could have been released from Gastrin MNPs during their 24 h traf
ﬁcking in the endo lysosome compartment prior to magnetic ﬁeld ap
plication. Consequently, these results indicate that MILH induced ROS
production was the result of enhanced Fenton reaction catalysis using
cellular lysosomal iron or possibly iron from MNPs, dissolved most
likely before AMF application.
Secondly, we evaluated the temperature rise during MILH experi
ments. So far, our experimental data indicate that the death of cancer
cells in MILH occurs without any perceptible rise in the global tem
perature of the medium. The hypothesis that local heating occurs at
proximity of MNPs has been supported by several experimental reports
[27], but direct data accounting for such a phenomenon in MILH were
still lacking. In particular, no intracellular or intra lysosomal tem
perature measurement under magnetic hyperthermia experiments has
been reported so far in the literature. We therefore conducted such
experiments, using ﬂuorescent molecular thermometers and the pre
viously described miniaturized high frequency electromagnet which
enables confocal ﬂuorescence imaging of cells during MILH experi
ments [17]. Molecular thermometers were composed of the ﬂuorescent
moieties DY549 attached to MNPs via PolyEthyleneGlycol of 7 nm
2.10. Lipid peroxidation, mitochondrial membrane potential assay, DNA 
fragmentation, Il 1β secretion, Western blotting, analysis of lysosomal 
acidity
See Supplementary information and Supplementary Table 1.
3. Results
3.1. Magnetic Intra Lysosomal Hyperthermia (MILH) enhances ROS 
production through the Fenton reaction within lysosomes
Over expression of hormone receptors is a hallmark of neuroendo 
crine tumors which thus represent a perfect model for the experi 
mentation of tumor cell targeting with ligand grafted MNPs. We pre 
viously showed that Gastrin grafted iron oxide MNPs (termed Gastrin 
MNP) are internalized speciﬁcally by the pancreatic endocrine tumoral 
cells INR1G9 overexpressing the CCK2R (INR1G9 CCK2R cells) through 
a CCK2R dependent physiological process, and are then traﬃcked to 
lysosomes where they accumulated (Fig. 1a). Of note, Gastrin MNPs 
exist under nano objects containing nanoparticles and serum adsorbed 
proteins whose distribution slightly increased from a size around 37 to 
50 nm after 24 h of incubation in cell culture medium (data not shown). 
Upon AMF exposure, Gastrin MNPs killed 32.3 ± 2.7% of INR1G9 
CCK2R cells by a phenomenon that we termed “Magnetic Intra Lyso 
somal Hyperthermia” (MILH) [4] (Fig. 1a). 4 h after MILH treatment, 
the rate of cell damage reached 19.9 ± 1.5% (i.e. 3.5 ± 0.3 fold 
basal) as indicated by AnnexinV and propidium iodide (AnnV/PI) la 
belings (Fig. 1a). Both AnnV and PI labelings, which constitute early 
features of MILH cell death, were thus used throughout our study to 
appreciate cell death.
So far, our current knowledge on the mechanism of cancer cell 
death caused by MILH treatment is still elusive, although we and others 
identiﬁed cellular ROS production and lysosome leakage as biological 
events accompanying cell death [4,5,17]. To gain insight into cell death 
mechanisms, we hypothesized that AMF application to cells containing 
MNPs would generate a local temperature elevation and, inasmuch as 
MNPs are concentrated into lysosomes, heating of lysosome content 
would trigger a death signaling cascade initiated by the enhancement of 
ROS production within lysosomes. Indeed, in addition to being a major 
digestive compartment, lysosomes are well known major sites of ROS 
production through the Fenton reaction (Fe2+ +H2O2 → 
Fe3+ +OH  +OH%) which catalyzes the transformation of hydrogen 
peroxide to hydroxyl radicals. This reaction is dependent on low mo 
lecular weight iron derived from degraded iron containing proteins, 
lysosomal lumen acidity and temperature [18 20]. It is also known that 
high levels of ROS cause lysosome membrane permeabilization (LMP) 
whereby lysosomal cathepsins, as well as other hydrolytic enzymes, are 
released from the lysosomal lumen to the cytosol and trigger cell death 
(Fig. 1a b) [21]. In INR1G9 CCK2R cells, MILH increased ROS levels by 
5.7 ± 1.5 fold over the basal value (Fig. 1b, S1a). Such eﬀect is po 
tentiated by the addition of FeCl3 which increased ROS levels to 
7.5 ± 0.7 fold. In contrast, intralysosomal chelation of iron by Des 
ferrioxamine (DFO) [22] prevented MILH increased cellular ROS pro 
duction which returned nearly to the basal value (2.0 ± 0.5 fold over 
basal). Also, the inhibition of the vacuolar H+ ATPase pump by Baﬁ 
lomicyne A (BafA1) treatment which caused intralysosomal pH rise 
(Fig. S1b) decreased MILH induced cellular ROS level to 2.7 ± 0.4 
fold over basal value (Fig. 1b, S1a). Conversely, treatment of cells by 
Artesunate (ART), an activator of vacuolar H+ ATPase pump de 
creasing intralysosomal pH (Fig.S1b) [20], increased MILH enhanced 
cellular ROS production from 5.7 ± 1.5 to 8.3 ± 0.3 fold over basal 
value (Fig. 1b, S1a).
We previously showed that ROS production was signiﬁcantly de 
tectable after 30 min of AMF exposure [17]. To precisely identify 
subcellular site(s) of ROS which are initially produced in MILH condi 
tion, a series of experiments combining confocal microscopy imaging
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length or the Yellow Fluorescent Protein (YFP) linked to Lysosome
Associated Membrane Protein 1 (Lamp1) [4]. Intensity of ﬂuorescence
emission of the two probes was previously shown to depend on tem
perature [28]. This relationship was conﬁrmed by the calibration curve
showing linearity of ﬂuorescence intensity decrease as a function of
temperature increase (Fig. S3). Quantitative ﬂuorescence imaging was
then carried out on cells exposed to AMF for a limited duration (˂10
min) and incubated with ROS scavenger NAC in order to preserve ly
sosome integrity and avoid possible chemical quenching of the ﬂuor
escent molecular thermometers by ROS. As shown on Fig. 1e, ﬂuores
cence intensity of DY549 grafted to MNPs declined with the time of
AMF exposure. According to the calibration curve (Fig. S3), the per
centage of decrease of ﬂuorescence intensity observed after ~7 min of
treatment corresponds to a temperature increase of 14.1 ± 1.4 °C,
indicating that the temperature actually reached 51 °C at 7 nm distance
from the MNP core. However, ﬂuorescence intensity of YFP Lamp1 did
not signiﬁcantly change during MILH experiments (Fig. 1e). These re
sults strongly support that AMF exposure to MNPs that have been ac
cumulated in lysosomes causes a signiﬁcant temperature increase at the
immediate vicinity of the MNPs since it is not detected at the outer
surface of lysosomes.
3.2. MILH enhanced ROS production within lysosomes causes lysosomal
membrane permeabilization and cell death
We further assessed the relationship between ROS generation within
lysosomes and cell damage. ROS can destabilize and permeabilize ly
sosome membranes through lipid and protein peroxidation [3]. We
performed experiments combining confocal microscopy imaging and
pharmacological agents to analyze whether MILH induces the perox
idation of lysosomal lipids (Fig. 2a). Analysis of confocal microscopy
images indicated that MILH enhanced the level of lipid peroxidation
which was detectable from 30 min of AMF application, and co localized
with Gastrin MNPs (% of relative ﬂuorescence: 74.4 ± 2.7% vs
41.5 ± 5.6%). Moreover, intralysosomal chelation of iron by DFO or
BafA1 treatment decreased MILH induced lysosomal lipid peroxidation
(54.4 ± 3.1% and 48.7 ± 15.1%). Together, these results demon
strate that MILH induces lysosomal lipid peroxidation concomitantly
with lysosomal ROS production.
Since MILH stimulates lysosomal ROS production and lipid perox
ydation, it appeared likely that LMP subsequently occurs. Previously,
we documented that, in MILH experiments, lysosomal integrity was
aﬀected as suggested by the decrease of lysosome labeling by
LysoTracker. However, the criterium of LysoTracker labeling is
insuﬃcient to characterize LMP since it may account for leaking of low
molecular weight components and not lysosomal enzymes which are
key actors in lysosome functions. Herein, we determined whether ROS
production in lysosomes truly triggered LMP. The decrease of CathB
content in lysosomes (labeled with RFP Lamp1) was chosen to re
present lysosomal enzyme leakage (Fig. 2b). In absence of AMF appli
cation, INR1G9 CCK2R cells having internalized Gastrin MNPs pre
sented a high level of GFP CathB/RFP Lamp1 colocalization which was
reduced by the application of AMF (Pearson coeﬃcient: 0.54 ± 0.03 vs
0.69 ± 0.02 in presence vs absence of AMF). The eﬀect of MILH on
GFP CathB/RFP Lamp1 colocalization was cancelled in the presence of
the NAC scavenger (Pearson coeﬃcient: 0.74 ± 0.03, Fig. 2b, S4).
Moreover, quantiﬁcation of ﬂuorescence intensity showed that MILH
decreased lysosomal CathB levels by 19.2 ± 3.7% (% of relative
ﬂuorescence: 30.7 ± 3.9% vs 50.5 ± 3.8%), whereas addition of NAC
prevented it (50.3 ± 5.8%). These results demonstrate that lysosomal
leakage was entirely related to MILH enhanced ROS production.
We then determined whether the leakage of CathB from lysosomes
constituted an early event in the signaling cascade leading to cell death.
During MILH experiments performed using the miniaturized electro
magnet [17], we evaluated in real time the decrease of the colocaliza
tion of GFP CathB with RFP Lamp1, a protein resident of lysosome
membrane (Fig. 2c). Before or after AMF exposure, INR1G9 CCK2R
cells having internalized Gastrin MNPs presented a high level of GFP
CathB/RFP Lamp1 colocalization (Pearson coeﬃcient > 0.70). How
ever, the lysosomal CathB level decreased signiﬁcantly by
25.4 ± 4.7% and 43.9 ± 6.3% after 30 and 60 min of MILH treat
ment respectively, demonstrating that leakage of lysosome content is an
early event occurring concomitantly with the generation of lysosomal
ROS. Of note, RFP Lamp1 and GFP CathB ﬂuorescence intensities, other
LMP markers [29], decreased respectively by 20 ± 2.4% and
16.5 ± 6.6% from 30 min of AMF exposure (Fig. S7), strongly sug
gesting that the changes in RFP Lamp1 and GFP CathB ﬂuorescence
represent respectively lysosomal rupture and CathB leakage from ly
sosome into the cytosol and that both events occur early in the signaling
cascade leading to cell death.
Finally, we wished to establish the relationship between ROS gen
eration within lysosomes and cell death MILH experiments. We found
that the addition of FeCl3 or ART, which enhance ROS production in the
cell medium, augmented cell death induced by MILH (4.0 ± 0.3 and
4.1 ± 0.4 fold over basal value respectively vs 2.6 ± 0.2 fold in
presence of Gastrin MNP alone, Fig. 2d, S5). In contrast, NAC, DFO and
BafA1 treatments which trapped ROS or inhibited their formation,
prevented MILH induced cell death (0.8 ± 0.1, 1.4 ± 0.1 and
Fig. 2. MILH-induced ROS generation causes lysosome lipid peroxydation, lysosome membrane permeabilization and cell death.
a) INR1G9-CCK2R cells having or not internalized Gastrin-MNPs were incubated in the presence or absence of DFO or BafA1 and incubated with Image-IT® lipid peroxidation reagent
during the 30-min of AMF exposure. Left panel: confocal microscopy images illustrating lipid peroxidation in vesicles containing Gastrin-MNP labelings and line scans of ﬂuorescence
corresponding to peroxidized lipids colocalizing with Gastrin-MNPs. Right panel: Quantiﬁcation was performed by measuring the % of ﬂuorescence intensity of lipid peroxidation over
that of Gastrin-MNP from confocal microscopy images. Signiﬁcant diﬀerence compared to the control condition corresponding to cells containing Gastrin-MNPs in absence of AMF
exposure was indicated above histogram bar. Statistical signiﬁcances between other conditions are also indicated. 30–50 lysosomes of 20–30 cells/experiments were analyzed and results
are the mean ± SEM of 3 separate experiments. b) INR1G9-CCK2R transiently expressing GFP-CathB and RFP-Lamp1 were incubated with Gastrin-MNPs and exposed to AMF in the
presence or not of NAC. Left panel: LMP was evaluated by analyzing the colocalization between GFP-CathB and RFP-Lamp1 on confocal microscopy images using Pearson's coeﬃcient.
Signiﬁcant diﬀerence compared to the control condition corresponding to cells devoid of Gastrin-MNP in absence of AMF exposure was indicated above histogram bar. Statistical
signiﬁcances between other conditions are also indicated. Middle panel: confocal microscopy images illustrating GFP-CathB in lysosome labeled by RFP-lamp1 and line scans of
ﬂuorescence corresponding to GFP-CathB colocalizing with RFP-Lamp1. Right panel: LMP was quantiﬁed by measuring the % of ﬂuorescence intensity of GFP-CathB over that of RFP-
Lamp1 from confocal microscopy images. Signiﬁcant diﬀerence compared to the control condition corresponding to cells devoid of Gastrin-MNP and exposed to AMF was indicated above
histogram bar. Statistical signiﬁcances between other conditions are also indicated. 30–50 lysosomes of 20–30 cells/experiments were analyzed and results are the mean ± SEM of 4
separate experiments. c) INR1G9-CCK2R transiently expressing GFP-CathB and RFP-Lamp1 were incubated with Gastrin-MNPs and exposed or not to AMF. Diﬀerent positions were
marked inside (+AMF) and outside ( AMF) the gap of the electromagnet allowing to visualize the eﬀects of AMF under a confocal microscope. Top panel: Confocal microscopy images
illustrating the lysosome integrity in cells before and 60-min after AMF exposure (53 mT, 300 kHz). Bottom panel: Before and during AMF application, LMP was analyzed by measuring
the % of green pixels (GFP-CathB) colocalized with red pixels (RFP-Lamp1) (ImageJ software). Results are expressed as % of CathB/Lamp1 colocalization over control cells (in absence of
Gastrin-MNP and AMF). Signiﬁcant diﬀerence was analyzed comparatively to t= 0. 20–30 cells/experiments were analyzed and results are the mean ± SEM of 5 separate experiments.
d) INR1G9-CCK2R cells were incubated with Gastrin-MNPs, exposed to AMF in presence or not of diﬀerent agents. Dead cells were counted 4 h after AMF exposure by confocal
microscopy analysis of cells labeled with AnnV/PI. Results are expressed as fold change of death rate over control cells (in absence of Gastrin-MNP and AMF). The % of dead cells are
indicated above the histogram. Signiﬁcant diﬀerence compared to the control condition corresponding to cells devoid of Gastrin-MNP in absence of AMF exposure was indicated above
histogram bar. Statistical signiﬁcances between other conditions are also indicated. 2000–3000 cells/experiments were analyzed and results are the mean ± SEM of 4 separate ex-
periments. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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1.3 ± 0.1 fold over basal value respectively) (Fig. 2d, S4 S5). More
over, MILH induced cell death was not inhibited by rotenone or DPI
(Fig. S6), indicating that neither the mitochondria respiratory chain
complex nor NADPH oxidases were involved in cell death, further
supporting the idea that ROS generated by NADPH oxidases are sec
ondary to lysosomal stress caused by MILH treatment. All together,
these results demonstrate that lysosomal ROS production, which is
enhanced by MILH through the Fenton reaction, is at the origin of
cancer cell death.
3.3. Cancer cell death induced by MILH is dependent on CathB activity
In a previous study, we showed that MILH induced cell death de
pends on lysosomal cysteine cathepsins which include cathepsins B, C,
H, K, L, S and X [4]. Herein, we performed experiments to more pre
cisely identify the enzyme(s) involved. A likely candidate is CathB
which is involved in lysosomal cell death, abundant in lysosomes,
overexpressed in cancers and maintains its activity at neutral pH
[30 32]. MILH experiments were performed in the presence of the se
lective inhibitor of CathB CA 074 Me [33] or by overexpressing the
enzymatically inactive mutant GFP CathB C29A. As shown in Fig. 3a b,
both the inhibitor CA 074 Me and the inactive mutant GFP CathB C29A
prevented MILH induced cell death (1.2 ± 0.1 and 1.5 ± 0.1 fold
over basal value vs 2.5 ± 0.1 fold). In contrast, overexpression of wild
type CathB (GFP CathB WT) augmented the eﬃciency of MILH to era
dicate cancer cells (4.1 ± 0.2 vs 3.0 ± 0.3 fold over basal, Fig. 3c)
reaching 34.8% of dead cells comparatively to 17.3% of dead cells in
the absence of CathB WT overexpression. These results indicate that
cell death induced by MILH is dependent on CathB activity.
3.4. MILH induces cell death through a Caspase 1 dependent but Caspase 3
independent mechanism
So far, in most circumstances, partial LMP induce cell death through
an apoptotic pathway, by triggering a cascade of regulated molecular
events leading to activation of the eﬀector apoptotic enzyme Caspase 3
[3,14]. We therefore investigated whether MILH also induces cell death
through an apoptotic pathway. Surprisingly, the Caspase 3 inhibitor did
not inhibit MILH induced cell death (2.7 ± 0.2% vs 2.8 ± 0.2 fold
over basal) whereas it prevented cell death induced by staurosporine
used as a reference agent to stimulate apoptosis (Fig. 4a). Moreover,
Caspase 3 activation was not detected neither by confocal microscopy
using a ﬂuorescent substrate (Fig. 4b), nor by western blot as shown by
the absence of Pro Caspase 3 cleavage (Fig. S8). We also showed that
MILH did not modify mitochondrial outer membrane permeabilization
(MOMP), which critically relies on apoptotic cell death, as demon
strated with staurosporine treatment (Fig. 4c, S9), 4 h or 24 h after AMF
exposure [34]. Hence, cell death induced by MILH does not involve an
apoptotic pathway.
In some non epithelial cells, especially in macrophages exposed to
infectious agents, the release of lysosomal hydrolases such as CathB
induced after LMP was shown to activate a non apoptotic cell death
pathway involving Caspase 1 activation [35]. We therefore veriﬁed
Caspase 1 expression in INR1G9 CCK2R cells (Fig. S10) and determined
whether Caspase 1 was involved in MILH induced tumor cell death.
Incubation of INR1G9 CCK2R cells with Caspase 1 inhibitor prevented
cell death induced by MILH (1.6 ± 0.2 vs 2.8 ± 0.2 fold over basal,
Fig. 4d). Likewise, overexpression of Caspase 1 C284A inactive mutant
inhibited cell death (1.5 ± 0.2 vs 3.0 ± 0.2 fold over basal, Fig. 4e).
It was also noticed that overexpression of Caspase 1 C284A inactive
mutant lowered basal rate of cell death (amount of dead cells:
1.2 ± 0.4% vs 6.5 ± 0.9%). Moreover, MILH increased Caspase 1
activation (3.5 ± 0.4, 9.0 ± 1.3 and 12.5 ± 2.4 fold over basal 1 h,
4 h and 18 h after AMF exposure) and this activation was inhibited by
CathB inhibitor CA 074 Me (Fig. 4f, S11). It is also important to note
that 84.5 ± 2.3% of cells presenting an upregulated Caspase 1 activity
were labeled with AnnexinV (Fig. 4g). Taken together, these results
demonstrate that cell death induced by MILH does not involve an
apoptotic pathway, but requires Caspase 1 and Cath B activities.
An important function of Caspase 1 consists to process the precursor
of the inﬂammatory cytokines, interleukine 1β (Il1β) and interleukine
18 (Il 18) into their active forms [36]. Furthermore, activation of
Caspase 1 in cells is a hallmark of pyroptosis, which is a form of
regulated cell death, usually deﬁned by several additional biochemical
features such as independence of apoptotic caspases, Ann/PI positive
labeling, DNA fragmentation [37]. The current study demonstrates that
MILH induced cell death is dependent on Caspase 1 activation and
featured by Ann/PI labeling. Owing to functions of Caspase 1 in im
mune cells, we ﬁrst investigated whether MILH induced Caspase 1 ac
tivation was associated with Il1β secretion (Fig. 5a). Our results show
that, in INR1G9 CCK2R cells which were LPS primed or not, MILH did
not increase Il1β secretion relative to control cells. In contrast, in LPS
primed Thp1 macrophages, which were used as reference cells for Il1β
processing and secretion, levels of Il1β secretion were increased by
27.7 ± 3.2 fold over basal value. The levels of Il1β secretion by
INR1G9 CCK2R cells were very low (< 2 pg/mg of cell proteins) as was
that of Pro Il1β expression, comparatively to macrophages cells
(Fig. 5b). Hence, MILH induces Caspase 1 dependent cell death without
activating the Caspase 1 pro inﬂammatory response in the endocrine
tumoral INR1G9 CCK2R cells. However, we could not exclude that pro
inﬂammatory response could be activated by MILH in cancer cells ex
pressing higher level of Pro Il1β.
Then, we characterized DNA fragmentation caused by MILH using
TUNEL assay which consists in the incorporation of ﬂuorescent dUTP
(deoxyuridine triphosphate) into free 3′ hydroxyl termini generated by
genomic DNA fragmentation (Fig. 5c). Results indicate that, after 6 h of
AMF exposure, DNA fragmentation increased by 3.4 ± 0.5 fold re
lative to control cells (22.9 ± 3.8% vs 8.5 ± 1.4% of positive cells).
Of note, DNA fragmentation induced by MILH was less abundant than
that caused by staurosporine or by 42 °C water bath (40.1 ± 4.9% or
52.6 ± 14.0% of positive cells, respectively). Secondly, we char
acterized the type of DNA fragmentation caused by MILH (Fig. 5d). In
contrast to staurosporine treatment which provoked regular inter nu
cleosomic DNA fragmentation characterized by DNA ladder [37], MILH
did not induce the formation of the characteristic laddering pattern
associated with apoptosis. In conclusion, our results show that MILH
induced a non apoptotic Caspase 1 dependent cell death related to
pyroptosis which occurred without Il1β secretion and which was
characterized by the formation of TUNEL positive cells without ex
hibiting a laddering pattern [37,38].
Fig. 3. Cell death induced by MILH is dependent on CathB activity.
a) INR1G9-CCK2R cells having or not internalized Gastrin-MNPs were incubated with or without 10 μM CA-074-Me and exposed or not to AMF. Dead cells were counted 4 h after the end
of AMF exposure by confocal microscopy analysis of cells labeled with AnnV/PI. Results are expressed as fold change of death rate over control cells (in absence of Gastrin-MNP and
AMF). The % of dead cells are indicated above the histograms. b–c) INR1G9-CCK2R transiently expressing GFP-CathB-C29A inactive mutant (b) or GFP-CathB wild-type enzyme (c) were
incubated with Gastrin-MNPs and exposed or not to AMF. Dead cells were counted 4 h after the end of AMF exposure by confocal microscopy analysis and expressed as the % of cells
labeled with AnnV (red) among transfected (green cells) and non-transfected cells. Results are expressed as fold change of death rate over control cells (in absence of Gastrin-MNP and
AMF). The % of dead cells are indicated above the histograms. Signiﬁcant diﬀerence compared to the control condition corresponding to cells devoid of Gastrin-MNP in absence of AMF
exposure was indicated above histogram bar. Statistical signiﬁcances between other conditions are also indicated. 2000–3000 cells/experiments were analyzed and results are the
mean ± SEM of at least 4 separate experiments. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 4. Cell death lnduced by MILH 1s medlated tbrough a non..apoptotlc Caspase-1 slgnallng pa thway whlch 1s dependent on CathB actlvlty. 
INRlG9-ccK2R œlls havlng or not lntemallzed Gastrin-MNPs were exposed or not to AMF ln the presence or ln absence ofCaspase-3 or Caspase-1 lnhibitor. As positive and negatlve 
controls of apoptosls, INR1G9-0CK2R cens were stlmulated wlth 1 µM staurœporine ln the absence or ln the presence of Caspase-3 lnhlbitor. a) Dead cells were counted 4 h after the end 
of AMF exposure by confocal mlcroscopy analysls of cells labeled wlth AnnV /Pl. Results are expressed as fold change of death rate over control cells (ln absence of Gastrin-MNP and 
AMF). The% of dead cells 1s lndlcated above the histogram b) 4 h after AMF exposure or staurosporine treatment, Caspase-3 activation was analyzed by confocal mlcroscopy of cells 
labeled wlth FAM-PLICA-Casp3. Results are expressed as the% of total cells labeled wlth fluorescent Caspase substrate c) 4 h after AMF exposure or staurœpcrin e  treatment, cells were 
lncubated wlth JC-10 reagent and were analyzed by confocal mlcroscopy. Quantification of MOMP was performed by anal)'2ing the JC-10 green/red fluorescence ratio from confocal 
mlcroscopy Images. d) Dead cens were counted 4 h after the end of AMF exposure by con focal mlcroscopy anal ysls cf cells labeled with Ann V/Pl. Results are expressed as fold change of 
death rate over control cells (ln the absence of Gastrin-MNP and AMF). The% of dead œlls 1s lndlcated above the histogram e) INR1G9-CCK2R translentiy expresslng GFP-Casp l-C284A 
enzymatlcally Inactive mutant were lncubated wlth Gastrin-MNPs and exposed or not to AMF. Dead cells were counted 4 h after AMF exposure by confocal mlcroscopy analysls of cells 
labeled wlth Ann V. Results are expressed as fold change of death rate over control cells (ln absence of Gastrin-MNP and AMF). The% of dead cells 1s lndlcated above the hlstogram. 1) 4 h 
after AMP exposure, Caspase-1 activation was analy?Jed by confocal mlcroscopy of cells labeled wlth FAM-PLICA-Caspl. Results are expressed ln% of total cells labeled wlth fluorescent 
Caspase substrate. g) 4 h after AMF application cells were labeled wlth FAM-FUCA-Caspl, then wlth AnnV (red) and observed by confocal mlcroscopy. Signiflcantdifference compared to 
the control condition correspondlng to cells devoid ci Gastrin-MNP ln absence of AMF exposure was lndlcated above histogram bar. Statlstical signiflcances between other conditions are 
also lndlcated. 2000-3000 cells/experiments were analyzed and results are the mean ± SEM of at least 4 separate experiments. (For lnterpretation of the references to entour ln this 
figure legend, the reader 1s referred to the web version of this article.) 
3.5. Gastrin grafted MNPs mduces the death of cells expressing the CCK2R 
byMILH 
The preceding experiments analyzed the effects and mechanisms of 
MilR applied to the pancreat ic endocrine tumor œlls INR1G9 CCK2R. 
Herein, we extended the experiments to two other tumor œll lines, the 
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gastric cell line AGS CCK2R and the pancreatic cell line AR4 2.J, which 
express the CCK2R at low levels (-100 fmol/106 cells) (39). Cell sur 
vival data show that, 24 h after AMF exposure, MilR has eradicated 
22.0 ± 4.5% of AGS CCK2R œlls and 23.1 ± 1.3% of AR4 2 J œlls 
presenting Gastrin MNPs mainly in their lysosomes (Fig. 6a, S12). In 
the same conditions, 56.6 ± 4.0%> and 42.7 ± 6.4% of HEK CCK2R 
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cells were killed using 16 μg/ml or 1 μg Fe/ml of Gastrin MNP re
spectively (Fig. S13a b). Ann/PI labeling conﬁrmed that MILH induced
cell death was detectable 4 h post AMF (Fig. 6b) and dead cells were
more often labeled with PI in AGS CCK2R and AR4 2 J cells than in
INR1G9 CCK2R cells. MILH also triggered cell death in the non tumoral
embryonic kidney cell overexpressing the CCK2R (HEK CCK2R:
2.0 ± 0.2 pmol/106 cells) previously used to characterize uptake and
cellular traﬃcking of Gastrin MNPs (Fig. S13c) [4,40].
Determination of the uptake of Gastrin MNPs by the diﬀerent cells
indicates that receptor mediated uptake of MNPs by AGS CCK2R, AR4
2J and INR1G9 CCK2R cells was 0.83 ± 0.23, 0.60 ± 0.13 and
3.38 ± 0.74 pg of Fe/cell which corresponded to 0.52 ± 0.22,
0.14 ± 0.02 and 1.07 ± 0.28 pg of magnetic Fe/cell, respectively, as
measured by pEPR, after 24 h of intracellular accumulation (Fig. 6c). Of
note, in HEK CCK2R cells, Gastrin MNPs uptake was evaluated to be
4.01 ± 0.40 and 1.48 ± 0.22 pg of total and magnetic Fe/cell, re
spectively (Fig. S13d).
We ﬁnally assessed that the signaling pathway involved in MILH
induced cell death in AGS CCK2R, AR4 2J and HEK CCK2R cells was
similar to that identiﬁed in INR1G9 CCK2R. Firstly, no signiﬁcant
Caspase 3 activation could be detected in the 3 cell lines, similarly to
INR1G9 CCK2R cells (Fig. S13e, S14). Secondly, MILH increased
Caspase 1 activation, 4 h after AMF exposure, by 3.5 ± 0.1, 3.6 ± 0.2
and 6.2 ± 0.6 fold in AGS CCK2R, AR4 2J and HEK CCK2R respec
tively, similarly to INR1G9 CCK2R cells (Fig. 6d, S13f).
These above results demonstrate that MILH is eﬀective in inducing
the death of cancer cells from three diﬀerent types of cancer (pancreatic
endocrine, pancreatic exocrine and gastric) even if the targeted re
ceptor is expressed at low levels and if minute amounts of Gastrin MNPs
are internalized. Moreover, in the three cancers, as well as in HEK cells,
MILH induced cell death occurs through activation of Caspase 1 and
without activation of Caspase 3, indicating that MILH triggers a non
apoptotic cell death pathway following lysosome damage which is de
pendent on Caspase 1 activation.
4. Discussion
Following the publication of the proof of concept of anti cancer
nanotherapy using ligand grafted MNPs speciﬁcally internalized via cell
surface receptor, this study gained insight into the mechanisms at the
origin of cell death induced by MILH (Fig. 6e). Using Gastrin MNPs
which speciﬁcally target lysosomes of tumoral cells expressing the
CCK2R as a killing agent, we demonstrate that tumor cell death induced
by MILH occurs through a Caspase 1 dependent mechanism, but not an
apoptotic signaling pathway, since Caspase 3 was not activated. This
mechanism of MILH induced cell death was demonstrated in pancreatic
endocrine tumor cells as well as in gastric and pancreatic exocrine
tumor cells expressing the CCK2R.
MILH ﬁrst upregulates the catalysis of ROS production through the
Fenton type reaction within lysosomes which subsequently causes lipid
peroxidation, followed by LMP and the leakage of lysosomal content
into the cytosol. Among the lysosomal enzymes, CathB plays a critical
role in cell death and activates Caspase 1. Thus, MILH induced tumor
cell death can be related to pyroptosis mainly described in macro
phages, but rarely in epithelial cells [35,41,42]. Indeed, we showed that
dead cells present AnnV and/or PI positive labelings and irregular DNA
fragmentation (TUNEL positive staining without laddering pattern) as
previously observed in pyroptotic macrophages [37,38,43]. However,
whilst Caspase 1 dependent cell death by pyroptosis in macrophages is
usually associated with pro inﬂammatory responses resulting from
Caspase 1 cleavage of Il 1β and 18, MILH did not increase Il 1β clea
vage. These last results are in line with recent studies showing that
Caspase 1 can induce pyroptotic cell death independently of Il1 β
processing [44 46]. On the other hand, Pro Il1β is expressed at low
levels in our tumor cell model. Thus, we cannot not exclude that pro
inﬂammatory response would be activated by MILH in cancer cells
expressing higher level of Pro IL 1β.
Our current knowledge about Caspase 1 indicates that Caspase 1 is
synthesized as a cytosolic, inactive, monomeric zymogen (pro Caspase
1) that is thought to be activated by dimerization and autoproteolytic
processing, resulting in generation of large and small subunits (called
p20 and p10) of the catalytically active enzyme [47,48]. This activation
step is preceded by recruitment of Pro Caspase 1 into inﬂammasomes,
which are multiprotein signaling complexes. Furthermore, a direct
processing of Caspase 1 by CathB [49,50] or an indirect mechanism of
activation through CathB induced activation of inﬂammasome com
plexes [41,50 52] were reported. In the current study of MILH induced
cell death, CathB activation is critical for Caspase 1 activation and
tumor cell death indicating that one of these two mechanisms may
function, but this remains to be determined more precisely.
5. Conclusion
The present study provides essential new data on the mechanism
whereby targeted MNPs induce the death of tumor cells when exposed
to a high frequency magnetic ﬁeld. The central role of the Fenton re
action that produces ROS within lysosomes, together with that of CathB
and Caspase 1, represent the key elements which are the basis for the
optimization of Magnetic Intra Lysosomal Hyperthermia or MILH
strategies to kill cancer cells and their future developments as an anti
tumoral option.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jconrel.2017.11.050.
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